Clinical Trial Update: Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update from Seoul National University Hospital is evaluating genetic polymorphisms as predictors of methylphenidate response in Attenti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: UNKNOWN